Metropolitan Life Insurance Company (MetLife)’s C4 Therapeutics CCCC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-1,107
| Closed | -$3.48K | – | 2468 |
|
|
2023
Q1 | $3.48K | Sell |
1,107
-1,476
| -57% | -$4.64K | ﹤0.01% | 2286 |
|
|
2022
Q4 | $15.2K | Hold |
2,583
| – | – | ﹤0.01% | 2127 |
|
|
2022
Q3 | $22.7K | Hold |
2,583
| – | – | ﹤0.01% | 1969 |
|
|
2022
Q2 | $19.5K | Hold |
2,583
| – | – | ﹤0.01% | 2067 |
|
|
2022
Q1 | $62.7K | Sell |
2,583
-7,792
| -75% | -$189K | ﹤0.01% | 1465 |
|
|
2021
Q4 | $334K | Hold |
10,375
| – | – | ﹤0.01% | 1680 |
|
|
2021
Q3 | $464K | Buy |
10,375
+177
| +2% | +$7.91K | 0.01% | 1515 |
|
|
2021
Q2 | $386K | Buy |
10,198
+6,461
| +173% | +$244K | 0.01% | 1692 |
|
|
2021
Q1 | $138K | Hold |
3,737
| – | – | ﹤0.01% | 2260 |
|
|
2020
Q4 | $124K | Buy |
+3,737
| New | +$124K | ﹤0.01% | 2245 |
|